Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05550324 · ClinicalTrials.gov registry record
IPSC Repository of Pediatric Cardiovascular Disease
A clinical trial of Heart Diseases and Congenital Heart Disease, sponsored by Mingtao Zhao.
- Recruiting
- Registry status
- 300
- Enrollment target
- 1
- Study location
NCT05550324: Recruiting study of Heart Diseases and Congenital Heart Disease, sponsored by Mingtao Zhao.
NCT05550324 is a study of Heart Diseases and Congenital Heart Disease that is actively recruiting participants, run by Mingtao Zhao. The registered enrollment target is 300 participants, below the 5,529-participant average among 85 other Heart Diseases trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05550324, a study of Heart Diseases and Congenital Heart Disease, is actively recruiting participants, sponsored by Mingtao Zhao.
- RECRUITING
- Registry status
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
Obtain blood samples for generation and maintenance of induced pluripotent stem cells (iPSCs) and genomic/DNA sequencing for biomedical research that will improve the understanding and treatment of pediatric cardiovascular disease
Primary Outcome
This is a repository of blood samples that will be used into the future for medical research to improve the understanding and treatment of pediatric cardiovascular disease
Conditions Studied
Interventions
- PROCEDURE Blood draw
Study Locations (1)
Ohio
- Nationwide Children's Hospital - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2021-07-02 |
| Est. Completion | 2030-12-31 |
What NCT05550324 shows while recruiting
NCT05550324 is an observational study that tracks outcomes without assigning an intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 5,529-participant average among 85 other Heart Diseases trials with a reported enrollment target (95% lower).
The record links to 2 conditions, with Heart Diseases appearing as the primary indexed condition, and to 1 intervention - of which Blood draw is the first listed.
NCT05550324 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT05550324 about?
NCT05550324 is a clinical study titled "IPSC Repository of Pediatric Cardiovascular Disease". Obtain blood samples for generation and maintenance of induced pluripotent stem cells (iPSCs) and genomic/DNA sequencing for biomedical research that will improve the understanding and treatment of pediatric cardiovascular disease
What is the current status of trial NCT05550324?
This trial is currently recruiting. The enrollment target is 300 participants. The study started on 2021-07-02. Estimated completion is 2030-12-31.
What conditions does trial NCT05550324 study?
This clinical trial studies the following conditions: Heart Diseases, Congenital Heart Disease.
What interventions are being tested in trial NCT05550324?
The interventions under investigation include: Blood draw (PROCEDURE).
Who is sponsoring clinical trial NCT05550324?
This trial is sponsored by Mingtao Zhao, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05550324 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05550324's enrollment target sits among peer trials
300 48th of 85 higher than 36 of 85 other Heart Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Heart Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Angiography and Electrogram Guided Bachmann Bundle Pacing
RECRUITING · NA
-
Understanding Decentralized Trial Engagement and Clinical Impediments Through Digital Efforts (UDECIDE) Among Unrepresented Groups With Poor Cardiovascular and Cardiometabolic Health
RECRUITING · NA
-
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
RECRUITING · NA
-
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With at Least Mild FMR
RECRUITING · NA
-
Lumason® Infusion vs. Bolus Administrations
RECRUITING · Phase 3
-
American Indian Chronic Renal Insufficiency Cohort Study (AI-CRIC Study)
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI